Literature DB >> 3221987

Coagulation abnormalities in low birth weight infants with peri-intraventricular hemorrhage.

M Amato1, J C Fauchere, U Hermann.   

Abstract

Fifty-four appropriate for gestational age preterm infants (less than 35 weeks gestation) were followed prospectively from birth with coagulation and real-time ultrasound studies. Coagulation analyses included fibrinogen, prothrombin time, thrombin time and platelet count. The occurrence of peri-intraventricular hemorrhage (PIVH) was documented by portable 5 MHz Echo Scanner. Definite PIVH was present in 21 babies (38%). Coagulation studies showed especially lower values of fibrinogen levels in babies of less than 30 weeks gestation compared to a control group without PIVH (p less than 0.03). Furthermore, significant correlation was observed in these patients between platelet count and degree of PIVH. Infants with Grade 3 and 4 PIVH had lower platelet count than infants with less severe bleeding (Grade 1 and 2) (p less than 0.02). These data suggest that hemostatic abnormalities play a major role as co-factor in the incidence and severity of neonatal PIVH in very low birth weight infants of less than 30 weeks gestation.

Entities:  

Mesh:

Year:  1988        PMID: 3221987     DOI: 10.1055/s-2008-1052420

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  4 in total

1.  Coagulation screening tests in high risk neonates: a prospective cohort study.

Authors:  B K Schmidt; P Vegh; M Andrew; M Johnston
Journal:  Arch Dis Child       Date:  1992-10       Impact factor: 3.791

Review 2.  Neonatal transfusion practice.

Authors:  N A Murray; I A G Roberts
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-03       Impact factor: 5.747

Review 3.  Neonatal thrombocytopenia: causes and management.

Authors:  I Roberts; N A Murray
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-09       Impact factor: 5.747

Review 4.  Neuroprotection in preterm infants.

Authors:  R Berger; S Söder
Journal:  Biomed Res Int       Date:  2015-01-11       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.